Deerfield Partners, L.P., 10% Owner at Auspex Pharmaceuticals, Inc. (ASPX), bought 1,500,000 shares at $56.50 ($84.8M) on 2015-01-28, disclosed to the SEC on 2015-01-28.
Open-market purchase of $84.8M ASPX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.50 | 115,000 | $6.5M | 7.7% |
| 2 | $56.50 | 167,760 | $9.5M | 11.2% |
| 3 | $56.50 | 192,240 | $10.9M | 12.8% |
| 4 | $56.50 | 458,175 | $25.9M | 30.5% |
| 5 | $56.50 | 566,825 | $32.0M | 37.8% |
| Total | $56.50 avg |
| 1,500,000 |
| $84.8M |
| 100% |
| Filing → |
| ATRS | SELL | 2015-06-23 | $1.2M | — | Filing → |
| RIGL | BUY | 2011-06-07 | $5.2M | — | Filing → |
| MDCO | SELL | 2011-04-01 | $4.6M | — | Filing → |